'No Animal Sacrifice' Cellames Developing Alternative Animal Testing Methods
Bioelectronic technology company Cellames is developing animal alternative testing methods to replace animals sacrificed in animal experiments.
Cellames' cell analysis impedance measurement systems, CIMS-16 and CIMS-32, provide technology that can non-destructively monitor the state of cells such as growth, proliferation, and death in real time. Additionally, the cell local field potential (LFP) measurement systems CFPS-32 and CFPS-32-NR measure extracellular potentials according to cell excitation, which can be used for experiments such as drug toxicity evaluation and activity rate analysis. Besides these, Cellames also develops various cell chips for two-dimensional and three-dimensional cell analysis, offering solutions capable of analyzing organoids.
Cellames is reaching out to domestic bio-related research institutes, university laboratories, and companies, and plans to exhibit its products at a booth at the 2024 Society of Toxicology (SOT) Expo, the world's largest exhibition in the related field, held from April 11 to 13 (local time) in Salt Lake City, Utah, USA.
Hot Picks Today
"Why Live in Seoul When You Can Pay Half Here?" 30 Minutes to Gangnam... Private Sales Begin in Gyeyang New Town
- "Living Becomes Easier Thanks to SK Hynix, But Conservative U.S. Cities Remain Torn Inside [U.S. Midterm Election D-40]②-2"
- "I Went for the Cheap Coffee, but Now I Feel Uneasy"... Major Coffee Franchises Cited for Violations One After Another
- "Had All My Tickets Booked for Chuseok"... Measles Outbreak and Typhoon Cause Chaos, but Japan Remains Top Choice
- "After Spending 170,000 Won on Hanwoo, This Is What I Got": Why Webtoon Artist Kim Gyusam Decided to Give Cash Instead
Jangjun Cho, CEO of Cellames, said, "We aim to present a new paradigm that can save animals by developing a human cell-derived organoid analysis system that can improve the safety and efficacy evaluation of pharmaceuticals for humans compared to animals."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.